DDX17 and breast cancer: Therefore, changes in the expression of Ddx5 and Ddx17, in particular under the control of altered miRNAs in breast cancer, could play a role in resistance to tamoxifen, in particular owing to their effects on splicing of genes involved in resistance (see above).